Opus Genetics, Inc. Common Stock (IRD) Stock Price

IRDStock

$4.11+250.43%52W

Market Cap$341.93M

P/E—

PEG Ratio—

Div yield—

Beta0.68

IRD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-3.78%

Price vs S&P 500 (4W)15.13%

VGM Score42.13

Book Value / Share (Quarterly)$0.22

P/TBV (Annual)20.69x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-29.11%

Cash Flow / Share (Quarterly)$-0.55

Price vs S&P 500 (YTD)88.54%

Net Profit Margin (TTM)-892.36%

EPS (TTM)$-1.32

10-Day Avg Trading Volume0.74M

EPS Excl Extra (TTM)$-1.32

EPS (Annual)$-0.80

ROI (Annual)-300.97%

Gross Margin (Annual)87.50%

Net Profit Margin (5Y Avg)-2097.75%

Cash / Share (Quarterly)$0.84

Revenue Growth QoQ (YoY)-50.64%

ROA (Last FY)-98.70%

Revenue Growth TTM (YoY)-12.22%

EBITD / Share (TTM)$-0.57

ROE (5Y Avg)-156.92%

Operating Margin (TTM)-359.13%

Cash Flow / Share (Annual)$-0.50

P/B Ratio20.16x

P/B Ratio (Quarterly)9.03x

Net Income / Employee (Annual)$-1,836,700

EV / Revenue (TTM)20.92x

Net Interest Coverage (TTM)-32.83x

ROA (TTM)-222.99%

EV / EBITDA (TTM)8.62x

EPS Incl Extra (Annual)$-0.80

Current Ratio (Annual)6.43x

Quick Ratio (Quarterly)6.71x

3-Month Avg Trading Volume0.95M

52-Week Price Return250.43%

Revenue / Employee (TTM)$443,800

Tangible BV / Share (Quarterly)$38.85

P/S Ratio (Annual)21.80x

Asset Turnover (Annual)0.28x

52-Week High$5.81

Operating Margin (5Y Avg)-938.76%

EPS Excl Extra (Annual)$-0.80

26-Week Price Return7.47%

Quick Ratio (Annual)6.20x

13-Week Price Return-6.06%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)7.13x

Enterprise Value$250.73M

Asset Turnover (TTM)0.25x

Book Value / Share Growth (5Y)-53.37%

Revenue / Employee (Annual)$525,800

Pretax Margin (Annual)-349.33%

Cash / Share (Annual)$0.65

3-Month Return Std Dev68.92%

Net Income / Employee (TTM)$-3,960,400

ROE (Last FY)-323.11%

Net Interest Coverage (Annual)-0.91x

EPS Basic Excl Extra (Annual)$-0.80

Receivables Turnover (TTM)3.21x

Total Debt / Equity (Quarterly)0.07x

EPS Incl Extra (TTM)$-1.32

Receivables Turnover (Annual)3.18x

ROI (TTM)-301.00%

P/S Ratio (TTM)25.83x

Pretax Margin (5Y Avg)-2097.58%

Revenue / Share (Annual)$0.23

Tangible BV / Share (Annual)$20.08

Price vs S&P 500 (52W)232.12%

Year-to-Date Return100.50%

5-Day Price Return9.21%

EPS Normalized (Annual)$-0.80

ROA (5Y Avg)-90.83%

Net Profit Margin (Annual)-349.33%

Month-to-Date Return8.63%

EBITD / Share (Annual)$-0.62

Operating Margin (Annual)-271.90%

LT Debt / Equity (Annual)0.07x

ROI (5Y Avg)-151.28%

LT Debt / Equity (Quarterly)0.07x

EPS Basic Excl Extra (TTM)$-1.32

P/TBV (Quarterly)10.58x

P/B Ratio (Annual)9.03x

Pretax Margin (TTM)-892.36%

Book Value / Share (Annual)$0.22

Price vs S&P 500 (13W)-8.85%

Beta0.68x

P/FCF (Annual)21.63x

Revenue / Share (TTM)$0.14

ROE (TTM)-316.35%

52-Week Low$1.12

vGradeD

gGradeD

mGradeB

vgmGradeC

IRD Earnings Surprise History

Q2 25-0.12est. -0.26

Q3 25-0.25est. -0.13

Q4 25-0.21est. -0.10

Q1 26-0.75est. -0.14

Q2 26-0.08est. -0.16

IRD Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.16

4.20

4.23

4.22

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
IRDOpus Genetics, Inc. Common Stock	D	D	B	$4.11
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Opus Genetics, Inc. Common Stock

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing therapies for inherited retinal diseases and other retinal and refractive disorders. Its pipeline includes AAV-based gene therapies for bestrophinopathy, Leber congenital amaurosis, and retinitis pigmentosa, along with small-molecule and ophthalmic solutions for diabetic retinopathy and pupil dysfunction.